New York State Teachers Retirement System Has $17.18 Million Stake in Albemarle Corporation $ALB

New York State Teachers Retirement System trimmed its stake in Albemarle Corporation (NYSE:ALBFree Report) by 6.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,719 shares of the specialty chemicals company’s stock after selling 6,060 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Albemarle worth $17,184,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in ALB. Evexia Wealth LLC grew its position in Albemarle by 2.3% during the first quarter. Evexia Wealth LLC now owns 2,088 shares of the specialty chemicals company’s stock valued at $387,000 after purchasing an additional 47 shares in the last quarter. Parallel Advisors LLC lifted its position in Albemarle by 2.5% in the 4th quarter. Parallel Advisors LLC now owns 2,468 shares of the specialty chemicals company’s stock worth $349,000 after buying an additional 60 shares in the last quarter. Eaton Financial Holdings Company LLC boosted its stake in shares of Albemarle by 1.2% during the 4th quarter. Eaton Financial Holdings Company LLC now owns 5,769 shares of the specialty chemicals company’s stock valued at $816,000 after buying an additional 66 shares during the period. Signature Estate & Investment Advisors LLC boosted its stake in shares of Albemarle by 1.9% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 3,592 shares of the specialty chemicals company’s stock valued at $508,000 after buying an additional 67 shares during the period. Finally, Assetmark Inc. grew its holdings in shares of Albemarle by 10.9% during the 4th quarter. Assetmark Inc. now owns 782 shares of the specialty chemicals company’s stock valued at $111,000 after acquiring an additional 77 shares in the last quarter. 92.87% of the stock is currently owned by institutional investors and hedge funds.

Albemarle Stock Down 0.2%

ALB opened at $135.27 on Friday. The firm has a market cap of $15.95 billion, a P/E ratio of -39.67, a price-to-earnings-growth ratio of 0.65 and a beta of 1.34. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.21 and a current ratio of 2.07. The business has a 50 day moving average price of $170.05 and a 200 day moving average price of $169.20. Albemarle Corporation has a twelve month low of $64.24 and a twelve month high of $221.00.

Albemarle (NYSE:ALBGet Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The specialty chemicals company reported $2.95 EPS for the quarter, beating the consensus estimate of $1.24 by $1.71. Albemarle had a positive return on equity of 5.22% and a negative net margin of 5.00%.The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter last year, the company posted ($0.18) earnings per share. The company’s revenue for the quarter was up 32.7% compared to the same quarter last year. Research analysts forecast that Albemarle Corporation will post 12.98 EPS for the current year.

Albemarle Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 1st. Investors of record on Friday, June 12th were paid a $0.405 dividend. The ex-dividend date was Friday, June 12th. This represents a $1.62 dividend on an annualized basis and a yield of 1.2%. Albemarle’s dividend payout ratio (DPR) is presently -47.51%.

Analysts Set New Price Targets

Several brokerages recently issued reports on ALB. Berenberg Bank increased their price objective on Albemarle from $153.00 to $192.00 and gave the stock a “hold” rating in a report on Tuesday, June 2nd. Citigroup upgraded Albemarle from a “neutral” rating to a “buy” rating and set a $225.00 target price on the stock in a research note on Thursday, June 18th. HSBC upped their target price on Albemarle from $200.00 to $220.00 and gave the stock a “buy” rating in a research report on Monday, April 27th. Jefferies Financial Group cut their price target on Albemarle from $244.00 to $211.00 and set a “buy” rating for the company in a research note on Tuesday, June 30th. Finally, Royal Bank Of Canada lifted their price target on Albemarle from $253.00 to $257.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $199.58.

View Our Latest Report on Albemarle

Insider Buying and Selling

In other Albemarle news, CEO J Kent Masters sold 16,393 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $183.72, for a total transaction of $3,011,721.96. Following the completion of the transaction, the chief executive officer owned 87,519 shares of the company’s stock, valued at $16,078,990.68. The trade was a 15.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.42% of the stock is owned by company insiders.

Albemarle Profile

(Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.

See Also

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALBFree Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.